Brief: UCB Receives U.S. FDA Approval For Bimzelx® (Bimekizumab-Bkzx)

UCB SA

20/11/2024 12:22

Nov 20 (Reuters) - Ucb SA  UCB.BR :
    * UCB RECEIVES U.S. FDA APPROVAL FOR BIMZELX®
(BIMEKIZUMAB-BKZX)
AS THE FIRST IL-17A AND IL-17F INHIBITOR FOR ADULTS WITH
MODERATE-TO-SEVERE HIDRADENITIS SUPPURATIVA

Source text:  ID:nPn9zTJhra 
Further company coverage:  UCB.BR 

 ((Reuters.Briefs@thomsonreuters.com;))